COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 1097: Articles 10961-10970  | Next

Ensemble cryo-electron microscopy reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complex
Chen, J., Wang, Q., Malone, B., Llewellyn, E., Pechersky, Y., Maruthi, K., Eng, E. T., Perry, J. K., Campbell, E. A., Shaw, D. E., Darst, S. A.
10.1101/2021.11.10.468168 — Posted: 2021-11-12
CORSID enables de novo identification of transcription regulatory sequences and genes in coronaviruses
Zhang, C., Sashittal, P., El-Kebir, M.
10.1101/2021.11.10.468129 — Posted: 2021-11-12
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19
Esparza, T. J., Chen, Y., Martin, N. P., Bielefeldt-Ohmann, H., Bowen, R. A., Tolbert, W. D., Pazgier, M. J., Brody, D. L.
10.1101/2021.11.10.468147 — Posted: 2021-11-12
Expression and novel alternative purification of the recombinant nucleocapsid (N) protein of SARS-CoV-2 in Escherichia coli for the serodiagnosis of COVID-19
Rosales, J. D., Quintero, W., Cruz, J., Perdomo, B., Quintero, M., Bastidas, M., Lugo, J. D., Rodriguez, K. R., Freites-Perez, J. C., Castillo, A.
10.1101/2021.11.10.467990 — Posted: 2021-11-12
Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern
Marzi, A., Griffin, A., O'Donnell, K. L., Shifflett, K., Lavik, J.-P., Russell, P. M., Zimmerman, M. K., Relich, R. F.
10.1101/2021.11.10.468174 — Posted: 2021-11-12
Total virome characterizations of game animals in China reveals a spectrum of emerging viral pathogens
He, W.-T., Hou, X., Zhao, J., Sun, J., He, H., Si, W., Wang, J., Jiang, Z., Yan, Z., Xing, G., Lu, M., Suchard, M. A., Ji, X., Gong, W., He, B., Li, J., Lemey, P., Guo, D., Tu, C., Holmes, E. C., Shi, M., Su, S.
10.1101/2021.11.10.467646 — Posted: 2021-11-12
Understanding national trends in COVID-19 vaccine hesitancy in Canada - April 2020 to March 2021
Lavoie, K. L., Gosselin Boucher, V., Stojanovic, J., Gupta, S., Gagne, M., Joyal-Desmarais, K., Seguin, K., Sheinfield-Gorin, S., Ribeiro, P. A. B., Voisard, B., Vallis, M., Corace, K., Presseau, J., Bacon, S. L.
10.1101/2021.11.10.21266174 — Posted: 2021-11-11
Neutralization breadth of SARS CoV-2 viral variants following primary series and booster SARS CoV-2 vaccines in patients with cancer
Naranbhai, V., St. Denis, K. J., Lam, E. C., Ofoman, O., Garcia-Beltran, W. F., Berrios, C., Bhan, A. K., Gainor, J. F., Balazs, A. B., Iafrate, A. J., CANVAX Team
10.1101/2021.11.10.21265988 — Posted: 2021-11-11
Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK.
Campbell, C., Wang, T., Smith, D. A., Freeman, O., Noble, T., Varnai, K. A., Harris, S., Salih, H., Roadknight, G., Little, S., Glampson, B., Mercuri, L., Papadimitriou, D., Jones, C. R., Taylor, V., Chaudhry, A., Phan, H., Borca, F., Olza, J., Warricker, F., Romao, L., Ramlakhan, D., English, L., Klenerman, P., Andersson, M. I., Collier, J., Nastouli, E., Khakoo, S. I., Gelson, W., Cooke, G., Woods, K., Davies, J., Barnes, E., Matthews, P. C.
10.1101/2021.11.10.21265651 — Posted: 2021-11-11
ANALYSIS OF IMMUNE ESCAPE VARIANTS FROM ANTIBODY-BASED THERAPEUTICS AGAINST COVID-19.
Focosi, D., Maggi, F., Franchini, M., McConnell, S., Casadevall, A.
10.1101/2021.11.11.21266207 — Posted: 2021-11-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).